A phase II study of capecitabine plus oxaliplatin (XELOX): A new first-line option in metastatic colorectal cancer

Author: Makatsoris Thomas   Kalofonos Haralabos   Aravantinos Gerasimos   Papadimitriou Christos   Kastritis Efstathios   Rigatos Sotirios   Xiros Nikolaos   Petsas Theodore   Economopoulos Theofanis   Sakadamis Athanassios   Fountzilas George  

Publisher: Humana Press, Inc

ISSN: 1537-3649

Source: International Journal of Gastrointestinal Cancer, Vol.35, Iss.2, 2005-04, pp. : 103-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content